Skip to content

Evaluation of Sexual Function After Artificial Urinary Sphincter Implantation

Prospective Observational Study Evaluating the Sexual Function After Insertion of an Artificial Urinary Sphincter in Women

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07399509
Acronym
SPHINCTER
Enrollment
30
Registered
2026-02-10
Start date
2026-02-01
Completion date
2029-02-01
Last updated
2026-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Female Artificial Urinary Sphincter Implantation

Keywords

Artificial urinary sphincter, Urinary Incontinence, Sexual function, Sexual quality of life

Brief summary

Urinary incontinence (UI) is a common and disabling condition that affects millions of people worldwide and significantly impacts the quality of life of those affected. It is well established that urinary incontinence negatively affects sexual life. Although there is no definitive consensus yet, many authors report that sexual function, after surgical intervention to restore continence, is likely to improve or, at the very least, remain unchanged.

Detailed description

The primary objective of the study is to evaluate sexual function in women 6 months after implantation of an artificial urinary sphincter. Patients will be informed during the preoperative consultation, with an information sheet provided. Consent to non-opposition will be collected either during the preoperative consultation or on the day of the procedure, if additional time for reflection is needed. Questionnaires will be completed during follow-up visits at 6 and 12 months postoperatively. The patients concerned are women who have undergone implantation of an artificial urinary sphincter. Patients will be informed during the preoperative consultation, with an information sheet provided. Consent to non-opposition will be collected either during the preoperative consultation or on the day of the procedure, if additional time for reflection is needed. Questionnaires will be completed during follow-up visits at 6 and 12 months postoperatively.

Interventions

OTHERquestionnaires

The PISQ-12 questionnaire, which explores female sexual function; the ICIQ-FLUTSsex questionnaire, which focuses on the impact of urinary leakage on sexuality; the USP questionnaire, which assesses the frequency and characteristics of urinary incontinence; and the Qualiveen-SF questionnaire, which measures the impact of these urinary disorders on daily life. A bladder diary was completed preoperatively as well as during follow-up visits at 6 and 12 months.

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Women aged 18 to 80 years * Patients with from urinary incontinence with an appropriate surgical indication for artificial urinary sphincter implantation * Patients who accept the surgical indication and have signed the informed consent for the procedure * No objection from the patients to participate in the study after reading the information sheet

Exclusion criteria

* \- Pregnant or breastfeeding patients * Life expectancy of less than 2 years * Patients who have undergone colpocleisis surgery * Patients with neurological conditions causing loss of sensation * Patients reporting no interest in sexual activity * Patients suffering from chronic pelvic pain

Design outcomes

Primary

MeasureTime frameDescription
Assess sexual function6 monthssexual quality of life assessed at 6 months post operatively by the PISQ-12 questionnaire (scale from 0 to 48).

Secondary

MeasureTime frameDescription
Assess sexual function12 monthssexual quality of life assessed at 12 months post operatively by the PISQ-12 questionnaire.
Assess sexual quality of life6 and 12 monthssexual quality of life assessed at 6 and 12 months post operatively by the ICIQ-FLUTSsex questionnaire.
Assess urinary incontinence (clinical efficacy)6 and 12 monthssexual quality of life assessed at 6 and 12 months post operatively by the USP questionnaire.
Assess quality of life6 and 12 monthsQuality of life assessed at 6 and 12 months post operatively by the Qualiveen SF questionnaire.
Assess complications6 and 12 monthsSurgical complications assessed at 6 and 12 months post according to the Calvien Dindo.

Countries

France

Contacts

CONTACTVéronique PHE, PU-PH
veronique.phe@aphp.fr01.56.01.61.95
CONTACTNour KHALIL, PhD
nour.khalil@aphp.fr01.56.01.61.95
PRINCIPAL_INVESTIGATORVéronique PHE, PU-PH

Assistance Publique - Hôpitaux de Paris

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026